doxofylline has been researched along with Disease Models, Animal in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Chen, ZY; Chu, SQ; Li, Y; Lin, YM; Wu, JH; Xie, WX; Zhang, XQ; Zhang, Y | 1 |
Page, CP; Riffo-Vasquez, Y; Venkatasamy, R | 1 |
Man, F; Page, CP; Riffo-Vasquez, Y | 1 |
4 other study(ies) available for doxofylline and Disease Models, Animal
Article | Year |
---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Effect of doxofylline on pulmonary inflammatory response and oxidative stress during mechanical ventilation in rats with COPD.
Topics: Animals; Disease Models, Animal; Inflammation; Interleukin-10; Male; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Random Allocation; Rats; Rats, Sprague-Dawley; Respiration, Artificial; Theophylline; Tumor Necrosis Factor-alpha | 2022 |
Steroid sparing effects of doxofylline.
Topics: Animals; Bronchodilator Agents; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Eosinophils; Female; Glucocorticoids; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred BALB C; Neutrophil Infiltration; Pneumonia; Theophylline | 2018 |
Doxofylline, a novofylline inhibits lung inflammation induced by lipopolysacharide in the mouse.
Topics: Animals; Anti-Inflammatory Agents; Bronchodilator Agents; Cell Movement; Disease Models, Animal; Dose-Response Relationship, Drug; Escherichia coli; Leukocytes; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Pneumonia; Theophylline | 2014 |